top of page


FDA Approves Ketamine as a Monotherapy for Treatment-Resistant Depression
ketamine is now approved by FDA for treatment resistant depression. Spravato is now available at clinics like Neuregen in Scottsdale, AZ.
David George
Jan 253 min read
bottom of page
